A carregar...
The risk of type 2 oral polio vaccine use in post-cessation outbreak response
BACKGROUND: Wild type 2 poliovirus was last observed in 1999. The Sabin-strain oral polio vaccine type 2 (OPV2) was critical to eradication, but it is known to revert to a neurovirulent phenotype, causing vaccine-associated paralytic poliomyelitis. OPV2 is also transmissible and can establish circul...
Na minha lista:
| Publicado no: | BMC Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5627419/ https://ncbi.nlm.nih.gov/pubmed/28974220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0937-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|